Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-10-06 2:42 pm Unchanged | 13D | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Frazier Life Sciences VIII L.P. | 10,542,790 24.1% | 0 (Unchanged) | View |
| 2020-02-10 4:39 pm Purchase | 13D | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | ORBIMED ADVISORS LLC | 4,067,564 10.7% | 4,067,564 (New Position) | View |
| 2020-02-10 12:29 pm Purchase | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | FMR LLC | 4,059,009 11.575% | 4,059,009 (New Position) | View |
| 2020-02-07 4:16 pm Purchase | 13D | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Bain Capital Life Sciences Fund L.P. | 3,609,796 9.5% | 3,609,796 (New Position) | View |
| 2020-02-07 4:04 pm Purchase | 13D | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Frazier Life Sciences VIII L.P. | 10,542,790 27.7% | 10,542,790 (New Position) | View |